Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/27/19 → 07/2/22 |
Funding
- Kiniksa Pharmaceuticals Ltd.: $18,050.00
Phase 3, Double-Blind, Placebo-controlled, Randomized Withdrawal, Study with Open-label Extension, to Asses the Efficacy and Safety of Rilonacept in Subjects with Recurrent Pericarditis (RHAPSODY)
- Bag Ozbek, Ayse (CoPI)
- Kontzias, Apostolos (PI)
Project: Research